Clinical Trials Logo

Paralysis clinical trials

View clinical trials related to Paralysis.

Filter by:

NCT ID: NCT00845442 Completed - Clinical trials for Vocal Cord Paralysis

Dynamic Laryngeal Opening for Bilateral Vocal Fold Paralysis by an Implanted Stimulator

Start date: January 1, 2006
Phase: N/A
Study type: Interventional

People who had paralysis of the vocal cords are often prevented from breathing by this problem because the cords will not open, and the patients have to wear a tracheostomy (neck breathing tube) to bypass this airway obstruction. This study examines the effects of vocal cord opening triggered by a pacemaker implanted over the chest wall. The device is connected to a nerve taken from a muscle close to the larynx (voice box) and implanted into the paralysed laryngeal muscle so it can reinnervate it. When this process is complete after a few weeks, the stimulator is turned on and the level of vocal cord opening is assessed. Airway improvement is checked by pulmonary function tests and measurements of vocal cord opening. The ultimate goal of the study is to lead to situations where patients with bilateral vocal fold paralyses could get rid of the neck breathing tube to have less complications, be more comfortable and socially acceptable.

NCT ID: NCT00703677 Completed - Clinical trials for Progressive Supranuclear Palsy

A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration

Start date: September 2008
Phase: Phase 1/Phase 2
Study type: Interventional

The goal of this trial is to evaluate the safety and tolerability of lithium in people with progressive supranuclear palsy or corticobasal degeneration.

NCT ID: NCT00689234 Recruiting - Clinical trials for Phrenic Nerve Paralysis

Diaphragm Plication in Adults With Phrenic Nerve Paralysis

Start date: April 2008
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate the impact of unilateral or bilateral diaphragm plication in a prospective randomised controlled way on symptoms, pulmonary function including gas exchange, respiratory muscle strength, exercise capacity and breathing during sleep in patients with proven uni- or bilateral phrenic nerve paralysis present for at least 1 year without any evidence of spontaneous recovery.

NCT ID: NCT00680264 Recruiting - Cerebral Palsy Clinical Trials

Prospective Database Registry Study of Scoliosis in Children With Cerebral Palsy

PCPS
Start date: June 2008
Phase:
Study type: Observational

The purpose of this study is to determine the radiographic and clinical outcomes of Scoliosis surgical and non-operative treatment in patients with Cerebral Palsy.

NCT ID: NCT00636519 Completed - Healthy Volunteers Clinical Trials

Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB Muscle

Start date: February 2008
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is: 1. To evaluate the model determined by the ability of botulism antitoxin (bivalent, Aventis) to neutralize Botulinum toxin in the Extensor Digitorum Brevis model of muscle paralysis in Stage A. 2. To assess the ability of botulism antitoxin (heptavalent, Cangene) to neutralize Botulinum toxin in the Extensor Digitorum Brevis model of muscle paralysis in Stage B.

NCT ID: NCT00629070 Completed - Cerebral Palsy Clinical Trials

Quadriceps Muscle Plasticity in Children With Cerebral Palsy

Start date: January 2009
Phase: N/A
Study type: Interventional

Our primary aim is to determine whether and how muscle architecture of the quadriceps muscles in cerebral palsy (CP) adapts to two separate training programs: traditional strength training (ST) vs. velocity-enhanced training (VT). For the ST group, we hypothesize that muscle size will increase in conjunction with strength. For the VT group, in addition to the above, we hypothesize that fiber length will increase with measures of muscle power. We also hypothesize that walking velocity will improve in both groups but that knee motion and step length will improve only with VT.

NCT ID: NCT00626951 Completed - Paralysis Clinical Trials

Crossover Study With the ProSeal and Supreme Laryngeal Mask Airway

Supreme
Start date: December 2007
Phase: N/A
Study type: Interventional

The LMA Supreme is a new extraglottic airway device which brings together features of the LMA ProSeal, Fastrach and Unique. We test the hypothesis that ease of insertion, oropharyngeal leak pressure, fiberoptic position and ease of gastric tube placement differ between the LMA ProSeal and the LMA Supreme in paralyzed anesthetized patients

NCT ID: NCT00623389 Recruiting - Stroke Clinical Trials

Evaluation of an Advanced Lower Extremity Neuroprostheses

LE-IST
Start date: June 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate a surgically implanted functional electrical stimulation (FES) system to facilitate exercise, standing, stepping and/or balance in people with various degrees of paralysis.

NCT ID: NCT00605930 Completed - Clinical trials for Progressive Supranuclear Palsy

A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.

Start date: April 2004
Phase: N/A
Study type: Interventional

This study intends to study the safety and tolerance of the combination of pyruvate, creatine, and niacinamide over 6 months in patients with PSP.

NCT ID: NCT00597844 Completed - Clinical trials for Unilateral Vocal Cord Paralysis

Improving Functional Outcomes in Patients With Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging

Start date: July 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to see how the brain re-learns to control the larynx in speaking and swallowing when undergoing surgical rehabilitation in the form of either thyroplasty or vocal fold augmentation for unilateral vocal cord paralysis. What is needed is information on how the brain re-learns to control speaking and swallowing so that we can eventually learn how to help patients re-learn faster after their procedure. Functional Magnetic Resonance Imaging (or fMRI) will allow us to image your brain as you speak and swallow. We will produce "brain maps" for speaking, swallowing and hand movements.